-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Nika Pharmaceuticals, Inc quarterly/annual Revenues history and growth rate from Q1 2022 to Q2 2024.
- Nika Pharmaceuticals, Inc Revenues for the quarter ending June 30, 2024 was $156.000.
- Nika Pharmaceuticals, Inc annual Revenues for 2023 was $0.000.
- Nika Pharmaceuticals, Inc annual Revenues for 2022 was $0.000.